Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Monks

Showing results (41-50 of 171) with videos related to

Pageof 18
Sort By:
Australian Veterinary Journal|April 29, 2014
Granuloma formation and suspected neuropathic pain in a domestic pigeon (Columba livia) secondary to an oil-based, inactivated Newcastle disease vaccine administered for protection against pigeon paramyxovirus-1M L Cowan, D J Monks, S R Raidal
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylationS S Lau, H E Kleiner, T J Monks
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2004
Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cellsDouglas C Jones, Serrine S Lau, Terrence J Monks
Molecular Pharmacology|July 1, 1990
Oxidative cyclization, 1,4-benzothiazine formation and dimerization of 2-bromo-3-(glutathion-S-yl)hydroquinoneT J Monks, R J Highet, S S Lau
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1984
Identification of 2-bromohydroquinone as a metabolite of bromobenzene and o-bromophenol: implications for bromobenzene-induced nephrotoxicityS S Lau, T J Monks, J R Gillette
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1984
Diffusion of reactive metabolites out of hepatocytes: studies with bromobenzeneT J Monks, S S Lau, J R Gillette
Toxicology and Applied Pharmacology|December 1, 1992
The effects of 2,3,5-(triglutathion-S-yl)hydroquinone on renal mitochondrial respiratory function in vivo and in vitro: possible role in cytotoxicityB A Hill, T J Monks, S S Lau
The American Journal of Physiology|November 15, 1997
PGE2-mediated cytoprotection in renal epithelial cells: evidence for a pharmacologically distinct receptorT J Weber, T J Monks, S S Lau
American Journal of Physiology. Renal Physiology|February 9, 2000
DDM-PGE(2)-mediated cytoprotection in renal epithelial cells by a thromboxane A(2) receptor coupled to NF-kappaBT J Weber, T J Monks, S S Lau
Chemical Research in Toxicology|July 1, 1995
Metabolism of 5-(glutathion-S-yl)-alpha-methyldopamine following intracerebroventricular administration to male Sprague-Dawley ratsR T Miller, S S Lau, T J Monks
Pageof 18

Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
Australian Veterinary Journal|April 29, 2014
Granuloma formation and suspected neuropathic pain in a domestic pigeon (Columba livia) secondary to an oil-based, inactivated Newcastle disease vaccine administered for protection against pigeon paramyxovirus-1M L Cowan, D J Monks, S R Raidal
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylationS S Lau, H E Kleiner, T J Monks
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2004
Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cellsDouglas C Jones, Serrine S Lau, Terrence J Monks
Molecular Pharmacology|July 1, 1990
Oxidative cyclization, 1,4-benzothiazine formation and dimerization of 2-bromo-3-(glutathion-S-yl)hydroquinoneT J Monks, R J Highet, S S Lau
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1984
Identification of 2-bromohydroquinone as a metabolite of bromobenzene and o-bromophenol: implications for bromobenzene-induced nephrotoxicityS S Lau, T J Monks, J R Gillette
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1984
Diffusion of reactive metabolites out of hepatocytes: studies with bromobenzeneT J Monks, S S Lau, J R Gillette
Toxicology and Applied Pharmacology|December 1, 1992
The effects of 2,3,5-(triglutathion-S-yl)hydroquinone on renal mitochondrial respiratory function in vivo and in vitro: possible role in cytotoxicityB A Hill, T J Monks, S S Lau
The American Journal of Physiology|November 15, 1997
PGE2-mediated cytoprotection in renal epithelial cells: evidence for a pharmacologically distinct receptorT J Weber, T J Monks, S S Lau
American Journal of Physiology. Renal Physiology|February 9, 2000
DDM-PGE(2)-mediated cytoprotection in renal epithelial cells by a thromboxane A(2) receptor coupled to NF-kappaBT J Weber, T J Monks, S S Lau
Chemical Research in Toxicology|July 1, 1995
Metabolism of 5-(glutathion-S-yl)-alpha-methyldopamine following intracerebroventricular administration to male Sprague-Dawley ratsR T Miller, S S Lau, T J Monks
Pageof 18